Shares of flu test kit and mask up

Published: 2009-08-24 06:56:00

Updated: 2009-08-24 06:56:00

As H1N1 influenza has once again become a national public health concern in Korea, the share prices of Bioland, a local diagnostic kit maker, saw its equity prices surge 14.60% on 12,950 won on August 20.

Bioland said in a press release that the company is exclusively supplying its diagnostic ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK